Abstract 4143552: Prognostic Value of Peak Circulatory Power Versus Peak Oxygen Uptake in Patients with Repaired Tetralogy of Fallot

Background: Cardiopulmonary exercise testing (CPET) is an essential tool for identifying early signs of clinical deterioration in patients with congenital heart disease (CHD), primarily through the measurement of peak oxygen uptake (VO 2 ). Circulatory power (CircP), a less commonly evaluated variable derived from CPET, has been proposed as a surrogate for cardiac power. However, there is limited direct comparative data on CircP to inform prognostic assessment in these patients. Objective: This study aimed to investigate the prognostic value of peak CircP in individuals with repaired Tetralogy of Fallot (rToF) compared to peak VO 2 . Methods: Forty-seven rToF patients underwent CPET between August 2014 and April 2018 at Memorial Healthcare System, Hollywood, Florida. The Cox proportional hazards model assessed CPET variables associated with major adverse cardiac events (MACEs), adjusting for covariates. Optimal cut-off values for CircP and peak VO 2 were derived from the receiver operating curve (ROC). Kaplan-Meier survival plots illustrated the prognostic significance of CircP and peak VO 2 . Results: Among the 47 patients, 9 experienced MACEs during the follow-up period. Multivariable Cox regression identified that both CircP and peak VO 2 independently predicted MACEs ( p = 0.029 and p = 0.041, respectively). The optimal prognostic threshold value for CircP was 3225 mm Hg mL/kg/min, with an area under the ROC curve (AUC) of 0.93 (95% confidence interval [CI]: 0.84-1.0, p < 0.001), sensitivity of 88.9%, and specificity of 92.1% (Figure 1A). The optimal prognostic threshold value for peak VO 2 was 21.2 mL/kg/min (AUC = 0.91, 95% CI: 0.82-1.0, p < 0.001; sensitivity = 77.8%, specificity = 89.5%) (Figure 1B). AUC values were comparable between CircP and peak VO 2 in predicting MACEs (0.93 vs 0.91, p = 0.777) (Figure 1C). Individuals with CircP < 3225 mm Hg mL/kg/min or peak VO 2 < 21.2 ml/kg/min had a significantly higher MACE risk than those with CircP ≥ 3225 mmHg.ml/kg/min or peak VO 2 ≥ 21.2 ml/kg/min (Figure 2, A and B). Conclusions: The prognostic significance of peak CircP was comparable to peak VO 2 in predicting MACEs in rToF patients. Peak CircP may serve as an independent marker for risk stratification in rTOF patients.